Class III beta-tubulin expression and benefit from adjuvant cisplatin/vinorelbine chemotherapy in operable non-small cell lung cancer: analysis of NCIC JBR.10.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples